E-ISSN:2456-3110

Research Article

PCOD symptoms

Journal of Ayurveda and Integrated Medical Sciences

2024 Volume 9 Number 9 SEPTEMBER
Publisherwww.maharshicharaka.in

A retrospective analysis of the Svayampurna Upacara Therapy in addressing PCOD symptoms

Chandorkar A1*, Chandorkar Y2, Shelage N3
DOI:10.21760/jaims.9.9.5

1* Amruta Chandorkar, Principal Investigator, Niraamay Wellness Center, Pune, Maharashtra, India.

2 Yogesh Chandorkar, Director, Niraamay Wellness Center, Pune, Maharashtra, India.

3 Nikita Shelage, Senior Medical Writing Associate, Department of Medical Writing, Jehangir Clinical Development Centre Pvt Ltd, Pune, Maharashtra, India.

Introduction: This study assesses the efficacy of Svayampurna Upacara therapy, a holistic energy-based treatment, in managing Polycystic Ovarian Syndrome (PCOS). Conducted retrospectively on 150 women treated from 1995 to 2024 at Niraamay Wellness Center in Maharashtra, the study included energy healing, yoga, and meditation counselling over 12 weeks. The therapy aims to balance Panch Tattva (five elements) and align Chakras to address the root causes of PCOS symptoms.

Materials and Methods: The study was conducted on 150 women with PCOS, using Svayampurna Upacara therapy. Over 12 weeks, participants underwent energy healing, Yoga, and meditation counselling, focusing on balancing Panch Tattva and Chakra alignment. Outcomes were assessed using McNemar's Chi-square test.

Results: The results showed significant improvements in menstrual cycle regularity and reduced dysmenorrhea severity. Body Mass Index (BMI) management was more effective in underweight and normal BMI participants, with modest changes observed in higher BMI individuals, likely due to Pruthvi and Jal Tattva imbalances. Additionally, there were notable improvements in hirsutism, hair shedding, acne severity, and emotional parameters, as measured by the Depression, Anxiety, and Stress Scale-10.

Discussion: The study highlights the potential of Svayampurna Upacara therapy in stabilizing mood swings and enhancing emotional well-being by addressing Tattva imbalances. However, the findings underscore the need for further research with larger, controlled studies to validate these results and establish the treatment's clinical efficacy. Overall, Svayampurna Upacara therapy offers a comprehensive approach to managing PCOS, addressing both physical and emotional health through energy balancing techniques.

Keywords: Energy-based treatment, Menstrual regularity, Panch Tattva balancing, PCOS management, Svayampurna Upacara therapy

Corresponding Author How to Cite this Article To Browse
Amruta Chandorkar, Principal Investigator, , Niraamay Wellness Center, Pune, Maharashtra, India.
Email: 		Chandorkar A, Chandorkar Y, Shelage N, A retrospective analysis of the Svayampurna Upacara Therapy in addressing PCOD symptoms. J Ayu Int Med Sci. 2024;9(9):32-41.
Available From
https://jaims.in/jaims/article/view/3537

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2024-08-13 2024-08-23 2024-09-03 2024-09-13 2024-09-21
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Yes 12.32

© 2024by Chandorkar A, Chandorkar Y, Shelage Nand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

J Ayu Int Med Sci 2024;9(9)32
Amruta C et al. The Svayampurna Upacara Therapy

Introduction

According to World Health Organisation (WHO), Polycystic Ovary Syndrome (PCOS) is a prevalent hormonal disorder that impacts women of reproductive age, often beginning in adolescence with symptoms that can vary over time. The condition is estimated to impact 8–13% of women in their reproductive age, with up to 70% of cases going undiagnosed.[1]

The condition of PCOS is defined in research paper by Roya Rozati et.al as “hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology (PCOM), with a pivotal characteristic being the excessive production of androgens by the ovaries in the context of PCOS”.[2] Polycystic Ovary Syndrome (PCOS) commonly presents with menstrual irregularities and reproductive challenges, thereby serving as a prominent etiological factor in the perspective of female infertility.[3] As per World Health Organization (WHO), “Polycystic ovary syndrome symptoms may vary among individuals, changing over time and often occurring without a clearly identifiable trigger.[1] Possible symptoms include heavy, long, intermittent, and unpredictable or absent periods, infertility, acne or oily skin, excessive hair on the face or body male-pattern baldness or hair thinning, weight gain, especially around the belly, obesity.[1,4]

Erandi Hewawasam et.al mentioned in their published paper about women diagnosed with PCOS have higher Depression, Anxiety, and Stress Scale (DASS) scores, indicating a greater risk of psychological distress compared to women without PCOS.[5]

Managing reproductive dysfunction and insulin resistance (IR) often involves using oral contraceptive pills (OCP) to regulate menstrual cycles and reduce hirsutism and acne. However, prolonged OCP use is controversial due to potential adverse metabolic and cardiovascular effects.[6]

M Ezhil et al. mentions “Naturopathy is characterized as a drug-free, noninvasive, logical, and evidence-based medical system that employs treatments using natural elements. These treatments are grounded in the theories of vitality, toxemia, the self-healing capacity of the body, and the principles of healthy living”.[7]

Svayampurna Upacara is a holistic therapy that balances the body’s five elements (Panchtatvas) by correcting the energy flow through the energy centers, Chakras.

This therapy is based on the principle that diseases including PCOD/PCOS arise due to imbalance in the body’s energy. By correcting this imbalance the therapy aims to bring back harmony and wellbeing without medication or physical intervention.

The Trivrutkarana (Three fold Chikitsa) Principle

All of nature including the human body is made up of five elements: Earth, Water, Fire, Air and Space. In any natural object or body three elements are primary and two are secondary. Diseases arise when there is an imbalance in these elements especially when the three primary elements - Earth, Water and Fire get out of harmony. The Trivrutkarana (Three fold chikitsa) Principle identifies these imbalances and uses the causal elements to balance and heal by harmonizing the affected elements.

Initial Assessment

The therapy begins with an assessment of the five elements - Earth, Water, Fire, Air, Space - to see how balanced they are in the body. Then an assessment of the seven chakras to see where the energy is blocked that affects the organs involved in PCOD/PCOS like ovaries, adrenal glands, pancreas, hypothalamus and pituitary gland.

Impact of Elemental Imbalances

Elemental imbalances can cause many health issues especially in PCOD/PCOS. An imbalance in Earth (Prithvi) causes ovarian instability, cysts and irregular periods due to sedentary lifestyle, bad diet or chronic stress. Water (Apa) imbalance causes fluid retention, worsening of cysts and PCOD symptoms due to dehydration, bad diet or emotional blockages.

Fire (Agni) imbalance causes metabolic dysfunction, insulin resistance and weight gain due to stress, bad diet or hormonal disturbances. Air (Vayu) imbalance causes circulation problem, irregular periods and low energy due to stress, inactivity or bad respiratory health. And finally, Space (Akasa) imbalance affects communication, mental clarity and emotional well-being and causes hormonal imbalance and stress.


J Ayu Int Med Sci 2024;9(9)33
Amruta C et al. The Svayampurna Upacara Therapy

Organ Specific Analysis

  • Ovaries: Earth, Water and Fire imbalance leads to cysts and irregular periods.
  • Adrenal Glands: Fire, Air and Space imbalance leads to stress and fatigue.
  • Pancreas: Fire, Earth and Water imbalance leads to insulin resistance and weight gain.
  • Hypothalamus: Air, Fire and Space imbalance leads to hormonal irregularities.
  • Pituitary Gland: Space, Water and Air imbalance affects endocrine balance.

Aim and Objectives

The primary objective of this study was to evaluate the efficacy of Svayampurna Upacara therapy in regularizing menstrual cycles in women diagnosed with Polycystic Ovarian Syndrome (PCOS). Additionally, the secondary objectives focused on assessing the success of Svayampurna Upacara therapy in reducing the severity of dysmenorrhea (painful menses) in these women. The study also aims to compare pre-treatment and post-treatment changes across various health parameters, including Body Mass Index (BMI), hirsutism, hair loss, acne severity, dry skin, and emotional well-being, in women undergoing this holistic therapy. These objectives collectively aim to determine the potential of Svayampurna Upacara as a comprehensive treatment for managing both the physical and emotional symptoms associated with PCOS.

Materials and Methods

Patients and Study Design

This retrospective, observational study that utilized existing data from the Svayampurna Upacara treatment administered to women diagnosed with PCOD/PCOS in Maharashtra. Over the past 12 years, Niramaya Wellness Center applied the Svayampurna Upacara method to address diverse health issues, promoting well-being for over one lakh patients. This study retrospectively analyzed data for women treated with Svayampurna Upacara for PCOD/PCOS. Data from 150 subjects who had participated in the treatment between 1995 and 2024 was considered. The data of Svayampurna Upacara treatment for around 12 weeks per subject was considered for this purpose.

In addition to the treatment, the program provided counseling and advice on meditation and yoga. Data had been collected from subjects during their visits. Coded, anonymized data collected throughout the treatment were transferred in Excel sheets to a contract research organization (CRO) for analysis. The study was approved by the Institutional Ethics Committee of Jehangir Clinical Development Centre and registered with the Clinical Trial Registry of India under registration number CTRI/2024/08/071930. The study adhered to the ethical guidelines outlined in the "Ethical Principles for Medical Research Involving Human Subjects" as specified in the Helsinki Declaration.

Statistical Analysis

Statistical analysis was conducted using Excel, where the McNemar chi-square test was applied to determine critical values, followed by shift analysis. Additionally, percentage response calculations were performed to further interpret the data.

Observations and Results

The Table no. 1 presents descriptive statistics for a sample of 150 subjects focusing on age, weight, and height. The average age of the participants was 31.10 years, with a mean weight of 59.71 kg and a mean height of 1.5667 meters. These statistics provide a comprehensive overview of the demographic and physical characteristics of the sample population, highlighting the variability within the group.

Table 1: Summary of subject Baseline demography

ParametersStatisticsValues (N = 150)
Age (Years)n150
Mean (SD)31.10 (7.786)
median31
max50
min12
Weight (Kg)n150
Mean (SD)59.71 (11.132)
median60
max95
min30
Height (m)n150
Mean (SD)1.5667 (0.10066)
median1.5849
max1.7983
min1.2192
Note: N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category.
SD = Standard Deviation.

J Ayu Int Med Sci 2024;9(9)34
Amruta C et al. The Svayampurna Upacara Therapy

The primary objective of this study was to evaluate change in menstrual cycle length post-treatment compared to baseline. For this purpose, data of 140 subjects was available for analysis, after excluding 10 subjects who reported to have conceived during their follow up visits. Results exhibit significant findings regarding menstrual cycle regularity. As per Table no. 2, of initial 80 subjects with regular cycles at baseline, 34 maintained regularity at last follow-up, indicating stability. Notably, 46 subjects initially reporting irregular cycles transitioned to regularity by final visit, suggesting substantial improvement. Conversely, all 60 subjects with irregular cycles at baseline continued to experience irregularity, showing persistence despite study period. Mc Nemar's Chi-square test[8] underscored these changes, yielding a χ² value of 43.02222, significantly surpassing critical value of 3.841459. This denotes a clear statistical significance, highlighting a notable increase in regular menstrual cycles over follow-up period.

Table 2: Summary of menstrual cycle length post-treatment compared to baseline

Baseline (N=140)
Last follow up visit (N = 140)Regular Menstrual cycle (n) (%)Irregular Menstrual cycle (n) (%)Total Subjects (n) (%)
Regular Menstrual cycle (n)344680 (57.14%)
Irregular Menstrual cycle (n)06060 (42.85 %)
Total Subjects (n)34 (24.28 %)106 (75.71%)140
Chi-square (χ²)43.02222
Chi-square Critical (χ²critical)3.841459
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category
χ² = Chi-square
χ²critical= Chi-square Critical

This study also aimed to assess the proportion of participants who self-reported a reduction in painful menses or dysmenorrhea. Table no. 3, shows changes in dysmenorrhea severity among 140 participants over time. Initially, 114 subjects reported experiencing dysmenorrhea, but by the final follow-up visit, this number had decreased to 88 subjects, while the number of subjects without symptoms increased from 26 subjects to 52 subjects. Statistical analysis revealed a significant association (χ² = 22.32143) between dysmenorrhea status at baseline and follow-up, indicating notable improvements in symptom severity.

Table 3: Summary of change in Dysmenorrhea Symptoms Severity compared to baseline

Baseline (N=140)
Last follow up visit (N = 140)
OutcomeNo dysmenorrhea (n)Dysmenorrhea (n)Total Subjects (n)
No dysmenorrhea (n)252752
Dysmenorrhea (n)18788
Total Subjects (n)26114140
Chi-square (χ²)22.32143
Chi-square Critical (χ²critical)3.841459
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category
χ²= Chi-square
χ²critical= Chi-square Critical

This study examined changes in Body Mass Index (BMI) grades[9] post-treatment compared to baseline. The shift analysis of the BMI data reveals that the Svayampurna Upacara treatment had varying impacts on participants based on their initial BMI categories. As per Table no. 4 participants with a baseline BMI of less than 17.0 showed that 2 subjects improved their BMI towards healthy BMI. Those starting with a BMI of less than 18.5 also saw positive changes, though a small group (2.66%) remained in the same category. The majority of participants in the normal BMI range (18.5-24.9) maintained their BMI, indicating that the treatment effectively helped sustain a healthy weight. In contrast, participants with higher BMI values (≥25.0 and ≥30.0) showed less dramatic shifts.

BMISvayampurna Upacara treatment
(N=150)
Last follow up visitBaseline
Outcome<17.0 BMI<18.5 BMI18.5-24.9 BMI≥25.0 BMI≥30.0
n (%)n (%)n (%)n (%)n (%)
<17.0 BMI7 (4.66)0 (0.0)0 (0.0)0 (0.0)0 (0.0)
<18.5 BMI1 (0.66)4 (2.66)0 (0.0)0 (0.0)0 (0.0)
18.5-24.9 BMI1 (0.66)2 (1.33)70 (46.66)0 (0.0)0 (0.0)
≥25.0 BMI0 (0.0)0 (0.0)10 (6.66)32 (21.33)1 (0.66)
≥30.00 (0.0)0 (0.0)0 (0.0)4 (2.66)18 (12.0)
Note:
N = Total number of subjects in treatment arm.n = Total number of non-missing subjects in specified category

Table 4: Summary of Change in Body Mass Index

Some in the ≥25.0 category moved to the normal range, but most stayed in their initial categories. Notably,


J Ayu Int Med Sci 2024;9(9)35
Amruta C et al. The Svayampurna Upacara Therapy

those with a BMI of 30.0 or higher saw minimal change, suggesting that while the treatment facilitated some weight loss, it was less effective in significantly reducing BMI for individuals with obesity. Overall, the treatment proved particularly beneficial for underweight participants, promoting weight gain and BMI improvement, while maintaining healthy BMI levels for those initially in the normal range.

Table no. 5 presents a detailed overview of participants' weight status changes during the study, categorized into four outcomes based on their Body Mass Index (BMI). Approximately 27.33% of participants maintained a healthy weight throughout, while 22% showed improvement by moving towards a healthier BMI category, demonstrating positive treatment effects. However, 24% experienced weight fluctuations: 22.66% saw an increase without reaching a healthy weight, and 1.33% decreased but remained outside the healthy range. Another 26.66% showed no change in weight status and did not maintain a healthy weight, suggesting potential areas for additional intervention or support.

Table 5: Summary of change in Weight from baseline to last follow-up visit

No change but maintained healthy weight n (%)Improvement in weight n (%)Fluctuations in weight n (%)No change but outside of healthy weight n (%)
IncreasedDecreased
N= 150
41 (27.33)33 (22)34 (22.66)2 (1.33)40 (26.66)
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category.

The Table no. 6, illustrates changes in hair growth status among 150 participants from baseline to the last follow-up visit, categorized by hirsutism scores. Change in hirsutism Clinical Score Post-Treatment as Assessed by the Ferriman-Gallwey Scale. Initially, 144 individuals were classified as having no hirsutism, which increased slightly to 146 by the end of the study. Conversely, the number of individuals classified with hirsutism decreased from 6 to 4 over the same period. This shift indicates a modest improvement in hair growth scores, with a small number of participants transitioning from the hirsutism category to the no hirsutism category by the study's conclusion.

Table 6: Change in hirsutism from baseline to last follow-up visit

Category of hair growthBaseline (n)Last follow-up visit (n)
N = 150
No hirsutism144146
Hirsutism64
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category

The study on participants with PCOD provides insights into changes in hair loss over time. According to Table no. 7, Change in hair loss score post-treatment as measured by the Hair Shedding Score.[11] Initially, a majority of participants (102 out of 150) continued to experience consistent hair loss from baseline to follow-up. However, significant shifts were observed in hair fall categories: the number of participants in the normal hair fall category increased from 7 (6.86%) to 10 (9.80%), indicating improvement for some. The borderline category also saw an increase from 40 (39.21%) to 53 (51.96%), suggesting more individuals moved from excessive to borderline hair fall. Conversely, cases of excessive hair fall decreased from 55 (53.92%) to 39 (38.23%), showing a positive reduction in severe hair loss. Overall, these findings reflect an overall improvement in hair fall conditions among the participants throughout the study period.

Table 7: Summary of subjects Response for hair loss

Are you suffering from hair loss after diagnosed with PCOD?Baseline (n)Follow-up (n)
N= 150
Yes102102
No4848
Category (Hair fall)Baseline n (%)Follow-up n (%)
N = 102
Normal7 (6.86)10 (9.80)
Borderline40 (39.21)53 (51.96)
Excessive55 (53.92)39 (38.23)
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category

The study also focused on post-treatment changes in acne scores, measured using the Global Acne Grading System (GAGS).[12] The Table no. 8, presents data comparing acne severity levels between baseline and the last follow-up visit. Across the severity categories, the majority of participants remained stable or saw minor changes in their acne status.


J Ayu Int Med Sci 2024;9(9)36
Amruta C et al. The Svayampurna Upacara Therapy

Specifically, the "No acne (0)" category showed an increase from 94 to 102 participants, indicating an improvement or maintenance of clear skin. Mild acne cases also increased slightly from 32 to 35. However, there was a notable decrease in severe acne cases, dropping from 8 to 1 participant, suggesting effective treatment or natural resolution over time. Moderate acne cases showed a decrease from 16 to 12, indicating some improvement but not as pronounced as in the severe category. Overall, the data suggest positive trends in acne management or natural progression over the study period, with fewer participants experiencing severe acne by the last follow-up visit.

Table 8: Summary of change in acne severity level from baseline to last follow-up visit

Severity LevelBaseline (n)Last Follow-Up Visit (n)
N=150
No acne (0)94102
Mild (1-18 acne)3235
Moderate (19-23 acne)1612
Severe (31-38 acne)81
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category

The study examined post-treatment changes in dry skin response, measured using the Dry Skin Classification Scale (DSCS)[13] compared to baseline. Table no. 9 illustrates changes in skin dryness conditions among participants between baseline and follow-up. The percentage of women with mildly dry skin increased from 27.33% to 31.33%, suggesting that 4% of women with moderate and severe dry skin converted to having mild dry skin. The combined category of moderately dry and severely dry skin decreased from 12% to 8%, indicating an improvement in skin condition for some participants. The proportion of women with no dry skin remained constant at 60.67%. Overall, these data suggest a slight improvement in skin dryness conditions over the study period.

Table 9: Change in Dry skin response from baseline to last follow up visit

Grading in SkinBaseline n (%)Last Follow up visit n (%)
N= 150
No Dry91 (60.67)91 (60.67)
Mildly Dry41 (27.33)47 (31.33)
Moderately Dry and Severely Dry18 (12)12 (8)
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category

The study assessed post-treatment emotional parameters using the Depression Anxiety Stress Scale (DASS-10). [14] Table no 10. Changes from baseline to the final follow-up, showing overall stability or improvement in most symptoms. Reductions were noted in nervousness (27.33%), irritation (46.00%), anxiety (40.00%), tension (37.33%), phobia (7.33%), less concentration (12.66%), and mood swings (44.00%). Slight escalations occurred in nervousness (2.00%), irritation (2.67%), hyperactivity (2.00%), anxiety (1.33%), tension (3.33%), and mood swings (2.00%). The results indicate a general trend toward reduced symptom frequency or stability over the follow-up period.

Table 10: Change in the response of emotional parameters from baseline to Last follow-up visit

CategoryGrading from baseline to Last follow-up visitn (%)
NervousnessNot changed106 (70.67)
Escalation3 (2.00)
Reduction in the frequency41 (27.33)
IrritationNot changed77 (51.33)
Escalation4 (2.67)
Reduction in the frequency69 (46.00)
Hyper activenessNot changed132 (88)
Escalation3 (2)
Reduction in the frequency15 (10)
AnxietyNot changed88 (58.66)
Escalation2 (1.33)
Reduction in the frequency60 (40)
TensionNot changed89 (59.33)
Escalation5 (3.33)
Reduction in the frequency56 (37.33)
PhobiaNot changed138 (92)
Escalation0 (0.0)
Reduction in the frequency11 (7.33)
Less concentrationNot changed131 (87.33)
Escalation0 (0.0)
Reduction in the frequency19 (12.66)
Mood swingsNot changed81 (54)
Escalation3 (2)
Reduction in the frequency66 (44)
Note:
N = Total number of subjects in treatment arm.
n = Total number of non-missing subjects in specified category

Discussion

The Svayampurna Upacara therapy protocol described focuses on holistic cleansing and balancing of vital energies, energy centers, and specific organs associated with PCOD.


J Ayu Int Med Sci 2024;9(9)37
Amruta C et al. The Svayampurna Upacara Therapy

Significant improvements were observed in menstrual cycle regularity, with a notable increase in participants transitioning from irregular to regular cycles. This underscores the treatment's potential in managing menstrual health conditions effectively. Additionally, reductions in dysmenorrhea severity highlight its symptomatic relief benefits. The study's findings suggesting improvements in menstrual cycle regularity and reduction in dysmenorrhea due to balancing Panch Tattva. Vayu Tattva predominance typically correlates with irregularities and pain, making individuals more susceptible to painful menstruation.[15] By addressing menstrual irregularities through Panch Tattva through Svayampurna Upacara therapy, the study indicates effective management of these symptoms.

BMI management showed greater improvements in underweight and normal BMI categories, with modest changes in higher BMI participants. This variability may be linked to Pruthvi and Jal Tattva imbalance, associated with fluid retention and weight gain. By addressing Pruthvi with Jal Tattva through treatment, there may be a potential mechanism for helping participants maintain a healthier BMI range.[16] This underscores the holistic approach of balancing Doshas in therapies like Svayaṃpūrṇa Upacāra, which could play a role in supporting weight management strategies tailored to individual Tattva profiles. Furthermore, improvements in hirsutism and hair shedding scores suggest positive outcomes in managing related symptoms.

In Svayampurna Upacara therapy, where treatment targets Panch Tattva and related energy centers imbalance[17] a notable outcome was observed with most participants maintaining a status of no hirsutism, and some individuals transitioning from hirsutism to no hirsutism. This suggests that addressing Panch Tattva imbalance may contribute to reducing hirsutism symptoms effectively. Acne severity and dry skin conditions also showed favorable trends, indicating comprehensive therapeutic effects. It appears that Svayampurna Upacara therapy may have balanced Agni Tattva and reducing excessive heat, resulting in a reduction in acne scores and observable improvement. This indicates that addressing Agni Tattva imbalance could play a significant role in managing acne symptoms effectively through treatment.[16,17]

Emotional parameters, as assessed by DASS-10, demonstrated stability or improvement in symptoms, emphasizing the treatment's potential psychological benefits. The therapy's focus on balancing Panch Tattva in individuals highlights its potential to stabilize mood swings and enhance emotional well-being.

Given that PCOS is characterized by hormonal imbalances and varied symptoms, including mood fluctuations, addressing Dosha balance holistically could provide comprehensive benefits in managing these aspects of the condition. This approach not only targets specific symptoms but also aims to promote overall emotional stability and quality of life in individuals with PCOS.[15]

By addressing underlying Tattva imbalances, such therapies may complement conventional approaches in managing PCOS symptoms and improving overall well-being. However, further research is needed to establish the specific mechanisms and long-term efficacy of such treatments in PCOS management.

The findings support Svayampurna Upacara as a holistic approach addressing diverse health aspects, warranting further exploration and application in clinical settings. Also Svayampurna Upacara includes yoga and meditation counselling, which supports the management of conditions like polycystic ovarian syndrome (PCOS) and infertility.

The results underscore the therapy's potential benefits in addressing multiple facets of health through energy cleansing and Chakra balancing techniques. Svayampurna Upacara faces challenges such as the complexity of diagnosing individual elemental imbalances and integrating with modern medicine, alongside issues with patient compliance and limited practitioner training. However, further prospective research with larger, controlled studies is needed to validate these findings and establish the treatment's efficacy more conclusively in clinical practice.

Conclusion

In conclusion, Svayampurna Upacara therapy demonstrates promising outcomes across various health parameters, particularly in managing menstrual irregularities, reducing symptoms like dysmenorrhea, and improving emotional stability through energy balancing techniques.


J Ayu Int Med Sci 2024;9(9)38
Amruta C et al. The Svayampurna Upacara Therapy

The therapy's holistic approach, addressing imbalances in Panch Tattva shows potential in enhancing overall well-being and managing conditions such as PCOS. Positive changes in BMI, hirsutism, acne severity, and emotional parameters further underscore its comprehensive therapeutic effects. While these findings are encouraging, larger controlled studies are necessary to validate its efficacy and broaden its application in clinical settings.

Acknowledgement

The authors wish to extend their sincere thanks to Dr. Arati Ranade, Head of Medical and Regulatory writing Department at Jehangir Clinical Development Centre Pvt. Ltd., Pune, for her technical support and assistance with the statistical analysis of the study data and the preparation of this manuscript.

References

1. World Health Organisation (WHO) [Internet]. [Cited 2024 August 29]. Available from: https://www.who.int/news-room/fact-sheets/detail/ polycystic-ovary-syndrome#:~:text=Polycystic%20ovary%20syndrome%20(PCOS)%20is,and%20cysts%20in%20the%20ovaries.
2. Roya R, Mohammad Akbar A, Wajeeda T, Avinash B, Humaira M, Avvari BB, Ayapati MG, Vikram AA, Taalia NA, Mohammed SA. An Indian evidence-based study of prevalence, phenotypic features, lifestyle modifications of polycystic ovarian syndrome patients. J. Gynecol. Women’s Health. 2021;21:556069.
3. Bharali MD, Rajendran R, Goswami J, Singal K, Rajendran V. Prevalence of polycystic ovarian syndrome in India: a systematic review and meta-analysis. Cureus. 2022 Dec;14(12).
4. Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society. 2019 Aug;3(8):1545-73.
5. Hewawasam E, Brennan L, Giles L, Hull ML, Short A, Norman R, Peña AS. Assessing whether meditation improves quality of life for adolescent girls with polycystic ovary syndrome: Protocol for a randomized controlled trial. JMIR Research Protocols. 2020 Jan 28;9(1):e14542.

6. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy in polycystic ovary syndrome: a systematic review. Human reproduction update. 2011 Mar 1;17(2):171-83.
7. Ratnakumari ME, Manavalan N, Sathyanath D, Ayda YR, Reka K. Study to evaluate the changes in polycystic ovarian morphology after naturopathic and yogic interventions. International Journal of Yoga. 2018 May 1;11(2):139-47.
8. Chi-square test, Fisher’s Exacttest, McNemar’s Test [Internet]. [Cited 2023 August 29]. Available from: https://mdozmorov.github.io/BIOS567.2017/presentations/08_FuncEnrich/08b_enrichment_stats.pdf
9. World Health Organisation (WHO) [Internet]. [Cited 2024 August 29]. Available from: https://www.who.int/data/nutrition/nlis/info/malnutrition-in-women#:~:text=BMI%20%3C18.5%3A%20 underweight,BMI%20%E2%89%A530.0%3A%20obesity
10. Lumezi BG, Berisha VL, Pupovci HL, Goçi A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2018 Dec 6;35(6):631-5.
11. Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: a retrospective study. F1000Research. 2017;6.
12. Sobhan M, Seif Rabiei MA, Amerifar M. Correlation between lipid profile and acne vulgaris. Clinical, cosmetic and investigational dermatology. 2020 Jan 21:67-71.
13. Guenther L, Lynde CW, Andriessen A, Barankin B, Goldstein E, Skotnicki SP, Gupta SN, Choi KL, Rosen N, Shapiro L, Sloan K. Pathway to dry skin prevention and treatment. Journal of cutaneous medicine and surgery. 2012 Jan;16(1):23-31.
14. Depression Anxiety Stress Scales - 10 (DASS-10) [Internet]. [Cited 2024 August 29]. Available from: https://novopsych.com.au/wp-content/uploads/2023/03/Depression-Anxiety-Stress-ten-item-DASS-10.pdf
15. Malik G, Panda JK, Tanwar S. Female Menstrual Cycle and its relation to Tridosha and Sapta Dhatu-A Literary Review. Journal of Ayurveda and Integrated Medical Sciences. 2024 May 6;9(3):150-5.


J Ayu Int Med Sci 2024;9(9)39
Amruta C et al. The Svayampurna Upacara Therapy

16. Jadhav R, More A, Vaidya S, Choudhary N, Dutta S, Kadu KS, Gajabe G. Characteristics of Polycystic Ovary Syndrome: A Case Report Investigating the Role of Kapha and Pitta Doshas. Cureus. 2024 Feb;16(2).
17. Understanding PCOS [Internet]. [Cited 2024 August 29]. Available from: https://naadwellness.com/ understanding-pcos.php


J Ayu Int Med Sci 2024;9(9)40